inflammatory bowel disease
Anti-TNFs have been running the table in inflammatory bowel disease, but that’s changing. And as it does, the market’s primed for a big expansion.
Takeda’s IBD awareness comic book campaign, a team-up with Marvel, ended with the Unbeatables prevailing over IBD—and evildoers, too.
The FDA served a Mylan plant with a warning letter, Takeda inked a microbiome GI deal with NuBiyota and China works on new trial data fabrication policies.
Gilead is planning its first foreign manufacturing facility, Takeda will develop an IBD drug from Finch while cutting 180 workers at Ariad after the buyout.